Novartis decides not to pursue further development of Aurograb(TM)
- Details
- Category: Novartis

Rivaroxaban Phase II Data in ACS to be Presented at AHA Congress in November
- Details
- Category: Bayer

Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania
- Details
- Category: Abbott

GlaxoSmithKline and Valeant Pharmaceuticals announce worldwide collaboration agreement
- Details
- Category: GlaxoSmithKline

Bristol-Myers Squibb and Pfizer Provide Update on Apixaban Clinical Development Program
- Details
- Category: Bristol-Myers Squibb

ADAGIO trial results show Azilect® slows progression of Parkinson's disease
- Details
- Category: Lundbeck

Brings complementary capabilities in India to address patient populations most at risk
- Details
- Category: Genzyme

More Pharma News ...
- Alpharma Responds To Unsolicited Proposal By King Pharmaceuticals, Inc.
- King Proposes Acquisition of Alpharma for $33 Per Share in Cash
- New Trial to Evaluate Nexavar® as Adjuvant Therapy in Liver Cancer
- Novo Nordisk joins the Call to Action for gender equality
- DAIICHI SANKYO continues its expansion in Germany and Europe
- Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance
- Nycomed - strong results in second quarter 2008